China Bio-Immunity Corporation has begun a voluntary recall of its rabies vaccines, which are produced under the JGAD label. In a routine test, the SFDA found the “possibility of a flaw” in one of its vaccines. At this point, no adverse reactions have been reported to the SFDA. The SFDA has shut down the production lines of the company until an investigation of the problem is completed. More details...
Stock Symbol: (OTCBB: CHHB)
Sorry... this feature or article is only available to subscribers.